Term Name: | cyclosporin A metabolite M13 |
---|---|
Synonyms: | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-9-(2-hydroxy-2-methylpropyl)-6,18,24-triisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,, AM4N9, cyclosporin A metabolite AM4N9, cyclosporin metabolite AM4N9, cyclosporin metabolite M13, cyclosporine A metabolite AM4N9, cyclosporine A metabolite M13, cyclosporine metabolite AM4N9, cyclosporine metabolite M13, M13 |
Definition: | A cyclosporin A derivative that is cyclosporin A in which the residue-9 N-methylleucine moiety has undergone oxidation so as to introduce a hydroxy group at the carbon bearing the two methyl groups, while the residue-4 N-methylleucine moiety has undergone N-demethylation. |
Ontology: | ChEBI [CHEBI:140166] ( EBI ) |